Development of the Metabolic Syndrome: Study Design and Baseline Data of the Lufthansa Prevention Study (LUPS), A Prospective Observational Cohort Survey

Dirk Müller-Wieland; Christiane Altenburg; Heiko Becher; Janine Burchard; Anett Frisch; Jan Gebhard; Jutta Haas; Volker Harth; Jörg Heeren; Johannes Hengelbrock; Maximilian von Karais; Birgit Knebel; Jörg Kotzka; Bernd Löwe; Nikolaus Marx; Hans Pinnschmidt; Alexandra Preisser; Matthias Rose; Barbara Sawitzky-Rose; Ludger Scheja; Claudia Terschüren; Monika Töller; Eik Vettorazzi; Karl Wegscheider

doi:10.1055/a-0767-6361

Experimental and Clinical Endocrinology & Diabetes, Table of Contents

Exp Clin Endocrinol Diabetes 2020; 128(12): 777-787
DOI: 10.1055/a-0767-6361

Article

Development of the Metabolic Syndrome: Study Design and Baseline Data of the Lufthansa Prevention Study (LUPS), A Prospective Observational Cohort Survey

Authors

Dirk Müller-Wieland

¹Department of Medicine I, University Hospital Aachen, Aachen, Germany
Christiane Altenburg

²Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Heiko Becher

³Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Janine Burchard

⁴Asklepios Medical School Campus Hamburg, Semmelweis University, Hamburg, Germany
Anett Frisch

⁴Asklepios Medical School Campus Hamburg, Semmelweis University, Hamburg, Germany
Jan Gebhard

⁵Aeromedical Center Lufthansa, Hamburg, Germany
Jutta Haas

⁴Asklepios Medical School Campus Hamburg, Semmelweis University, Hamburg, Germany
Volker Harth

⁶Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Jörg Heeren

⁷Department of Biochjemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Johannes Hengelbrock

³Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Maximilian von Karais

⁵Aeromedical Center Lufthansa, Hamburg, Germany
Birgit Knebel

⁸Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center at the Heinrich-Heine-University Düsseldorf, Leibniz Center for Diabetes Research, Düsseldorf, Germany
Jörg Kotzka

⁸Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center at the Heinrich-Heine-University Düsseldorf, Leibniz Center for Diabetes Research, Düsseldorf, Germany
Bernd Löwe

⁹Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Nikolaus Marx

¹Department of Medicine I, University Hospital Aachen, Aachen, Germany
Hans Pinnschmidt

³Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Alexandra Preisser

⁶Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Matthias Rose

¹⁰Department of Psychosomatic Medicine, Charite University Medical Center, Berlin, Germany
Barbara Sawitzky-Rose

¹¹Diabetes Center Berlin Rose, Berlin, Germany
Ludger Scheja

⁷Department of Biochjemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Claudia Terschüren

⁶Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Monika Töller

¹²Department of Endocrinology, Diabetology and Rheeumatology, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany
Eik Vettorazzi

³Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Karl Wegscheider

³Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Abstract

The Lufthansa Prevention Study (LUPS) study is a prospective observation of a healthy worker cohort to identify early changes in metabolism leading to the Metabolic Syndrome (MetS) and to analyze their relation to behavioral factors like nutrition, physical activity, psychological status, and to underlying genetic conditions. The LUPS study recruited a sample of 1.962 non-diabetic healthy adults between 25–60 years, employed at a flight base of Lufthansa Technik GmbH in Hamburg, Germany. Baseline assessments included anthropometric measures, blood and urine samples and medical history. Psychosocial variables, dietary habits and life-style risk factors were assessed via self-reported questionnaires.

In this report we describe the study design and present baseline parameters including the prevalence of the MetS using different classification criteria. The MetS was present in 20% of male and 12% of female subjects according to the ‘Harmonizing the metabolic syndrome’ definition. The prevalence varies between 2.6% in male and 2.3% in female subjects up to 48% in male and 41% in female subjects according to different classification criteria of MetS.

In conclusion, this first cross-sectional view on the LUPS data confirms the expectation that this cohort is rather healthy and thus provides the opportunity to analyze early changes associated with the development of the MetS. The LUPS study is registered as a clinical trial NCT01313156.

Key words

insulin resistance - nutrition - visceral obesity - dyslipidemia - fasting plasma glucose - depression

Full Text

References

References
1 Grundy SM, Brewer HB, Cleeman JI. et al. Definition of metabolic syndrome. Report of the national heart, lung, and blood institute/ american heart association conference on scientific issues related definition. Circulation 2004; 109: 433-438
2 Scherer PE. The multifaceted roles of adipose tissue: Therapeutic targets for diabetes and beyond: the 2015 Banting Lecture. Diabetes 2016; 65: 1452-1461
3 Stefan N, Kantarzis K, Häring HU. Causes and metabolic consequences of Fatty liver. Endocr Rev. 2008; 29: 939-960
4 Cornier MA, Dabelea D, Hernandez TL. et al. The metabolic syndrome. Endocr Rev 2008; 29: 777-822
5 Eckel RH, Alberti KG, Grundy SM. et al. The metabolic syndrome. Lancet 2010; 375: 181-183
6 Alberti KG, Eckel RH, Grundy SM. et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009; 120: 1640-1645
7 Spitzer RL, Kroenke K, Williams JBW. et al. Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. JAMA 1992; 282: 1737-1744
8 Löwe B, Kroenke K, Herzog W. et al. Measuring depression outcome with a brief self-report instrument: Sensitivity to change of the patient health questionnaire (PHQ-9). J Affect Disord 2004; 81: 61-66
9 Kroenke K, Spitzer RL, Williams JB. The PHQ-9. Validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613
10 Gräfe K, Zipfel S, Herzog W. et al. Screening psychischer störungen mit dem gesundheitsfragebogen für patienten (PHQ-D). Diagnostica 2004; 50: 171-181
11 Kroenke K, Spitzer RL, Williams JB. et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007; 146: 317-325
12 Löwe B, Decker O, Müller S. et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Medical Care 2008; 46: 266-274
13 Spitzer RL, Kroenke K, Williams JB. et al. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med 2006; 166: 1092-1097
14 Kroenke K, Spitzer RL, Williams JBW. et al. The patient health questionnaire somatic, anxiety, and depressive symptom scales: Asystematic review. Gen Hosp Psychiatry 2007; 32: 345-359
15 Interian A, Allen LA, Gara MA. et al. Somatic complaints in primary care: Further examining the validity of the patient health questionnaire (PHQ-15). Psychosomatics 2006; 47: 392-398
16 Kroenke K, Spitzer RL, Williams JB. The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64: 258-266
17 Schwarzer R, Jerusalem M. Generalized self-efficacy scale. In measures in health psychology: A user's portfolio. Causal and control beliefs. Weinmann J, Wright S, Johnston M. (Eds.) Windsor, UK: NFER-NELSON; 1995. pp 35-37
18 Levenstein S, Prantera C, Varvo V. et al. Development of the perceived stress questionnaire: A new tool for psychosomatic research. J Psychosom Res 1993; 37: 19-32
19 Fliege H, Rose M, Arck P. et al. The Perceived stress questionnaire (PSQ) reconsidered: Validation and reference values from different clinical and healthy adult samples. Psychosom Med 2005; 67: 78-88
20 Chaturvedi N, Stephenson JM, Fuller JH. et al. The relationship between smoking and microvascular complications in the EURODIAB IDDM complications study. Diabetes Care 1995; 6: 785-792
21 Tampere KHO. Finnish diabetes association. Implementation of the type 2 diabetes prevention project-plan 2003–2007.2006: Available from http://www.diabetes.fi/en/finnish_diabetes_association/diabetes_programme_de
22 Baecke JA, van Staveren WA, Burema J. Food consumption, habitual physical activity, and body fatness in young Dutch adults. Am J Clin Nutr 1983; 37: 278-286
23 Baecke JAH, Burema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936-942
24 Wagner P, Singer R. Ein Fragebogen zur Erfassung der habituellen körperlichen Aktivität verschiedener Bevölkerungsgruppen. Sportwissenschaft 2003; 33: 383-397
25 Toeller M, Frisch A, Müller-Wieland D. Fragebogen zur Erfassung der Nahrungsaufnahme in Risikogruppen (NARI). Diabetologie 2010; 5: 309-314
26 Tiepolt S, Liebert P, Pietrzik K. et al. Verzehrshäufigkeiten ballaststoffhaltiger Lebensmittel bei Diabetikern aus zwei Regionen Deutschlands. Implementierung der Ernährungsempfehlungen der Deutschen Diabetes-Gesellschaft. Aktuel Ernaehr Med 2002; 27: 157-166
27 Tiepolt S, Sowa P, Pietrzik K. et al. Verzehrshäufigkeiten fetthaltiger Lebensmittel bei Diabetikern mit unterschiedlichem Risikoprofil. Aktuel Ernaehr Med 2003; 28: 157-167
28 Tiepolt S, Sowa P, Pietrzik K. et al. Alkoholkonsum von Diabetikern in Deutschland. Ernährungs-Umschau 2003; 50: 332-339
29 Toeller M. Ernährung und Gesundheit – Die große Herausforderung für Prävention und Therapie: Diabetes als Modellbeispiel. CF-Journal aktuell Diabetes 2000; 5/6: 36-37
30 Petzoldt K. Drei Methoden zur Erfassung von Nahrungsfaktoren, die den Fettstoffwechsel beeinflussen. Untersuchung bei Diabetikern und Nichtdiabetikern. Medizinische Dissertationsschrift. Medizinische Fakultät, Heinrich-Heine Universität Düsseldorf, 1996
31 Heidemann C, Schulze MB, Franco OH. et al. Dietary Patterns and Risk of Mortality From Cardiovascular Disease, Cancer, and all Causes in a Prospective Cohort of Women. Circulation 2008; 118: 230-237
32 Deshmukh-Taskar PR, O'Neil CE, Nicklas TA. et al. Dietary patterns associated with metabolic syndrome, sociodemographic and lifestyle factors in young adults: the Bogalusa Heart Study. Public Health Nutr 2009; 12: 2493-2503
33 Max Rubner-Institut. , Bundesforschungsinstitut für Ernährung und Lebensmittel (Hrsg.) Nationale Verzehrsstudie II. Ergebnisbericht, Teil 1. Karlsruhe, Max Rubner-Institut, Bundesforschungsinstitut für Ernährung und Lebensmittel. 2008.http://www.was-esse-ich.de/uploads/media/NVS_II_Ergebnisbericht_Teil_1.pdf
34 Max Rubner-Institut. , Bundesforschungsinstitut für Ernährung und Lebensmittel (Hrsg.) Nationale Verzehrsstudie II. Ergänzungsband zum Ergebnisbericht, Teil 1. Karlsruhe, Max Rubner-Institut, Bundesforschungsinstitut für Ernährung und Lebensmittel.2008.http://www.was-esse-ich.de/uploads/media/Ergaenzungsbericht.pdf
35 Max Rubner-Institut. , Bundesforschungsinstitut für Ernährung und Lebensmittel (Hrsg.) (2008) Nationale Verzehrsstudie II. Ergebnisbericht, Teil 2. Karlsruhe, Max Rubner-Institut, Bundesforschungsinstitut für Ernährung und Lebensmittel. 2008.http://www.was-esse-ich.de/uploads/media/NVSII_Ergebnisbericht_Teil2.pdf
36 Gibson RS. Principles of Nutritional Assessment Second Edition. New York, Oxford: Oxford University Press; 2005. pp 27-64
37 Frisch A, Toeller M, Müller-Wieland D. Ernährungserhebungsmethoden in der Ernährungsepidemiologie. Diabetologie und Stoffwechsel 2010; 5: 301-308
38 Toeller M, Buyken AE, Heitkamp G. et al. Nutrient intakes as predictors of body weight in European people with type 1 diabetes. Int J Obes 2001; 25: 1815-1822
39 Bundeslebensmittelschlüssel (BLS) (vollständiger BLS, Lizenz und Updates), KarlsruheMax Rubner Institut, Bundesforschungsinstitut für Ernährung und Lebensmittel. Prodi. Ernährungsberatungs- und Diätberatungs-Programm 5.6, (1999-2008) WVG-Software mit Update auf CD-ROM. Wissenschaftliche Verlagsgesellschaft mbH (Nutri-Science GmbH), 2009
40 Milosavljevic D, Kontush A, Griglio S. et al. VLDL-induced triglyceride accumulation in human macrophages is mediated by modulation of LPL lipolytic activity in the absence of change in LPL mass. Biochim Biophys Acta 2003; 1631: 51-60
41 Bromberg IL, Zielinski N. Precision of the Roche Cobas Integra for general chemistry tests. Clin Chem 1996; 42: 164
42 Weykamp C, John WG, Mosca A. et al. The IFCC Reference Measurement System for HbA1c: A 6-Year Progress Report. Clin Chem 2008; 54: 240-248
43 Broekhuizen LN, Boekholdt SM, Arsenault BJ. et al. Physical activity, metabolic syndrome, and coronary risk: the EPIC-Norfolk prospective population study. Eur J Cardiovasc Prev Rehabil 2011; 18: 209-217
44 Haring R, Wallachofski H, Nauck M. et al. Total and cardiovascular disease mortality predicted by metabolic syndrome is inferior relative to its components. Exp Clin Endocrinol Diabetes 2010; 118: 685-691
45 Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, National Health and Nutrition Examination Survey, 1988-2012. Prev Chronic Dis 2017; 14: E24 doi:10.5888/pcd14.160287
46 McNeill AM, Rosamond WD, Girman CJ. et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk communities study. Diabetes Care 2005; 28: 385-390
47 Rathmann W, Haaster B, Icks A. et al. Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and association with C-reactive protein. Diabetes Care 2006; 29: 461
48 Han TS, Williams K, Sattar N. et al. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res 2002; 10: 923-931
49 Balkau B, Picard P, Vols S. et al. Consequences of change in waist circumference on cardiometabolic risk factors over 9 years: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2007; 30: 1901-1903
50 Rodriguez A, Muller DC, Engelhardt M. et al. Contribution of impaired glucose tolerance in subjects with the metabolic syndrome: Baltimore Longitudinal Study of Aging. Metabolism 2005; 54: 542-547
51 International Diabetes Federation. Worldwide definition of the metabolic syndrome.available http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf Accessed 2005 Aug 24
52 Einhorn D, Reaven GM, Cobin RH. et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003; 9: 237-252
53 World Health Organisation. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of WHO consultation. 1999; WHO/NCO/NCS/99.2